The authors hypothesized that pancreaticogastrostomy is safer than pancreaticojejunostomy afte pancreaticoduodenectomy and less likely to be associated with a postoperative pancreatic fistula
logistic regression analysis revealed the factors most highly associated with pancreatic fistula to be lower surgical volume and ampullary or duodenal disease in the resected specimen.
Conclusions
Pancreatic fistula is a common complication after pancreaticoduodenectomy, with an incidence most strongly associated with surgical volume and underlying disease. These data do not support the hypothesis that pancreaticogastrostomy is safer than pancreaticojejunostomy or is associated with a lower incidence of pancreatic fistula.
Pancreaticoduodenectomy has become increasingly accepted as a safe and appropriate operation for selected patients with malignant and benign diseases of the pancreas and periampullary region. The operative mortality rate after pancreaticoduodenectomy is 4% or less at major surgical centers. 1-5 Postoperative sepsis, hemorrhage, and cardiovascular events are responsible for the majority ofdeaths after pancreaticoduodenectomy.
Although the mortality rate after pancreaticoduodenectomy has decreased in recent years, the incidence of postoperative morbidity occasionally approaches 50%. [1] [2] [3] [4] [5] [6] [7] [8] In most series, the three leading causes of morbidity after pancreaticoduodenectomy are delayed gastric emptying, wound infection, and pancreatic fistula resulting from a pancreatic anastomotic leak."12'8"' Failure ofa pancreatic-enteric anastomosis to heal after pancreaticoduodenectomy can be a source ofconsiderable morbidity and can contribute to mortality. The incidence of pancreatic anastomotic leak ranges from 5% to 25% in most series. Because pancreatic fistula has been such a common problem after pancreaticoduodenectomy, various techniques of managing the pancreatic remnant (body and tail ofthe pancreas) have been studied.'2 Simple suture ligation of the pancreatic duct without enteric anastomosis was popular in past decades, 13 but has been largely abandoned due to an external fistula rate of more than 50%.'4 Pancreatic ductal occlusion with such substances as neoprene or prolamine has been proposed as a means of reducing fistula rates, with some reported success.'5"6 Various modifications of a pancreaticojejunal anastomosis have been tested, including site ofjejunum used (end vs. side), type of anastomosis (invagination vs. duct-to-mucosa), use of an isolated Roux-en-Y limb, and use of fibrin glue and pancreatic duct stenting. [17] [18] [19] [20] [21] [22] No universal agreement has been reached regarding one particular variation of pancreaticojejunostomy being safer and less prone to fistula formation.
A recently repopularized option for enteric drainage of the pancreatic remnant is pancreaticogastrostomy, a technique first reported on experiments in dogs in 193423 and used clinically for 50 years.24 '25 Reported results of pancreaticogastrostomy have been favorable, with very low rates of pancreatic fistula and mortality. [26] [27] [28] [29] To our knowledge, there has been no prospective randomized comparison between pancreaticogastrostomy and pancreaticojejunostomy after pancreaticoduodenectomy in humans. This prospective randomized single-institution trial was designed to test the hypothesis that pancreaticogastrostomy is safer than pancreaticojejunostomy and less likely to be associated with a postoperative pancreatic fistula.
METHODS
This study was approved by the Joint Committee on Clinical Investigation of the Johns Hopkins University School of Medicine. Patients were recruited into the study preoperatively, and appropriate informed consent was obtained. Between May 1993 and January 1995, 176 patients underwent pancreaticoduodenectomy at the Johns Hopkins Hospital. Of these, 146 patients (83%) were enrolled in this study. The reasons for nonenrollment of the remaining 30 patients were total pancreatectomy (n = 10), resection by nonparticipating surgeons (n = 16), and patient never recruited (n = 4).
Randomization and Exclusions
Enrolled patients (n = 146) were randomized intraoperatively after pancreaticoduodenal resection to either the pancreaticogastrostomy (PG) or pancreaticojejunostomy (PJ) group by means of a randomly generated number pattern. After enrollment and randomization, 1 patient was excluded from the analysis, leaving 145 patients in the study population. The No. 4 induced thromboemboli at the time of the preoperative arteriogram, which was performed for staging purposes. The patient required re-exploration for bleeding on the 12th postoperative day and died on the 22nd postoperative day.
Surgical Technique
Pancreaticoduodenal resection was performed as a partial pancreatectomy, with either classic resection (to include distal gastrectomy) or the pylorus-preserving modification.303' Octreotide was not used prophylactically in any patient, but was used postoperatively at the primary surgeon's discretion. Vagotomy, tube gastrostomy, or feeding jejunostomy was not performed in any patient. All hepaticojejunal anastomoses were stented (decompressed) through an operatively placed T tube or a preoperatively placed percutaneous transhepatic catheter. At the completion of the pancreaticoduodenal resection, the length ofmobilization ofthe pancreatic remnant and the diameter ofthe pancreatic duct (at the transected edge of the pancreatic neck) were measured. All pancreatic anastomoses were hand sewn and performed in two layers: 3-0 silk for the outer layer and 3-0 polyglactin (Vicryl; Ethicon, Johnson and Johnson, Somerville, NJ) for the inner layer. Pancreatic duct stents and fibrin glue were not used.
Pancreaticojejunostomy was performed in either endto-end or end-to-side fashion at the surgeon's discretion, as previously described.30 End-to-end PJ was favored and was most commonly performed (n = 48). End-toside PJ was used (n = 24) when there was a size discrepancy between a jejunum with a relatively small diameter and a pancreatic segment with a relatively large transected end. For either end-to-end or end-to-side PJ, the retained jejunum was brought through a rent in the right transverse mesocolon, with the PJ being performed to the proximal-most jejunum, followed by a standard endto-side hepaticojejunostomy and an end-to-side duodenojejunostomy or gastrojejunostomy. We accomplished pancreaticogastrostomy by anastomosing the pancreatic remnant to the posterior gastric wall midway between the lesser and greater curvature, at least 7 cm proximal to the pylorus or distal gastric staple line. The size of the posterior gastrotomy averaged 2.5 to 3 cm (Fig. 1) .
At the conclusion of the pancreaticoduodenal reconstruction, one or two '/4-inch round silicone closed-suction drains (ReliaVac; Davol, Cranston, RI) were introduced through separate left-sided abdominal stab incisions and placed in the vicinity of the pancreatic anastomosis. Additionally, one or two '/4-inch round silicone closed-suction drains were introduced through separate right-sided abdominal stab incisions and placed in the vicinity ofthe hepaticojejunostomy. 
Postoperative Management
Operatively placed drains in the vicinity ofthe pancreatic anastomosis were left undisturbed, with their outputs recorded daily for at least 5 postoperative days. Aliquots of the drainage were sent for amylase determination between postoperative days 3 and 7. A cholangiography, obtained through the T tube or percutaneous transhepatic catheter, and, in most cases, a water-soluble upper gastrointestinal series32 33 were performed on postoperative days 4 to 7 and were used to assess for leakage or obstruction at any of the three reconstructive anastomoses. In the absence ofa pancreatic fistula (radiographically documented leak or >50 mL drainage of amylaserich fluid on or after postoperative day 10), the drains were removed. In the presence of a pancreatic fistula, management was left to the discretion of the primary surgeon.
All patients received histamine H2-receptor antagonists (e.g., ranitidine, famotidine) during their postoperative hospitalization as prophylaxis for stress and marginal ulceration. The majority of patients received intravenous erythromycin lactobionate (200 mg intravenously every 6 hours from postoperative day 3 to 10) as prophylaxis for delayed gastric emptying.10
Data Collection
The preoperative, intraoperative, and postoperative care of each patient was directed by the attending surgeon, including the use and duration of prophylactic antibiotics, type of nutritional support, and time of re-moval of the nasogastric tube and operatively placed drains. Data were collected prospectively on all patients and included historic information, details of the operative procedure, a surgeon questionnaire (detailing such factors as pancreatic texture [soft, intermediate, hard], duct diameter, length of pancreatic remnant, and drain contact with the anastomosis), disease of the resected specimen, results of postoperative gastrointestinal contrast studies, and clinical information regarding the postoperative course (both in-hospital and after discharge).
Study End Points
The primary study end point was pancreatic fistula, defined as (1) drainage ofgreater than 50 mL ofamylaserich fluid (greater than threefold elevation above upper limit of normal in serum) through the operatively placed drains on or after postoperative day 10 or (2) pancreatic anastomotic disruption demonstrated radiographically.
Secondary study end points included assessment of postoperative complications (defined as those occurring during the hospitalization and including abdominal and extra-abdominal complications), length ofpostoperative hospital stay, and correlations between pancreatic fistula and multiple preoperative, intraoperative, and postoperative parameters. (55) 34 (47) 66 (90) 66 (92) 5 (7) 5 (7) 2 (3) 1 (1) 44 (60) 45 (63) 34 (47) 36 (50) 33 (45) 34 (47) 31 (42) 28 (39) 27(37) 32 (44) 22(30) 30 (42) 22(30) 18 (25) 10(14) 11 (15) 9(12) 11 (15) 37.1 ±0.6 36.8±0.6
9.3 ± 0. The study population consisted of 145 patients with a mean age of61.9 ± 1.1 years. Seventy-one patients (49%) were male, and 74 patients were female (5 1%). One hundred thirty-two patients (91 %) were white. Seventy-three patients were randomized to the PG group and 72 to the PJ group. No differences were observed between the PG and PJ groups on comparison of multiple patient characteristics and preoperative parameters ( Table 1) .
The pylorus-preserving modification of pancreaticoduodenectomy was performed in 119 patients (82%), whereas classic pancreaticoduodenectomy was performed in 26 patients (18%). No significant differences between the PG and PJ groups were observed on comparison of multiple intraoperative parameters ( Table 2 ). The pathologic findings in the resected specimens revealed malignant disease in 122 patients (84%) and benign disease in 23 patients (16%). Eighty patients (55%) had malignant tumors ofthe pancreas. In a stepwise multivariate logistic regression model (Table 5) , the strongest predictors of pancreatic fistula were surgical volume and ampullary or duodenal disease. Such parameters as operative time and pancreatic texture, which were significant predictors of pancreatic fistula by univariate analysis, failed to maintain statistical significance in the multivariate model. Adjustment ofthe multivariate model for the strongest predictive factors of surgical volume and ampullary or duodenal disease revealed that the risk of pancreatic fistula in the PG group was 1.76 times the risk in the PJ group (p = 0.36; NS), with a wide confidence interval (0.5-5.9). Table 6 shows a comparison of multiple postoperative parameters for the 17 patients with pancreatic fistula to the 128 patients without pancreatic fistula. Many parameters are significantly different in a comparison of these 47 19 0.01 41 14 0.01 24 5 0 Pancreaticogastrostomy has gained favor in recent years as a potential means of reducing the incidence of pancreatic fistula after pancreaticoduodenectomy.2629 Proponents of PG have noted several potential advantages. First, the PG anastomosis can be easier to perform, because the posterior wall of the stomach lies immediately anterior to the mobilized pancreatic remnant and is always wider than the transected pancreatic neck. Second, with PG, the pancreatic exocrine secretions enter the potentially acidic gastric environment, where the low pH prevents their activation. In contrast with PJ, the activation of pancreatic exocrine secretions in PG can theoretically occur more easily in the presence of intestinal enterokinase and a neutral pH. Third, the performance of PG reduces the number of anastomoses in a single loop of retained jejunum, thereby potentially decreasing the likelihood of loop kinking. Published single-institution studies have favored PG over pJ,38'39 although these studies are limited by their small patient populations, lack of randomization, and failure to document comparability between the two treatment groups with regard to risk factors for pancreatic fistula. Further, although a large meta-analysis has shown a significantly lower incidence of pancreatic fistula after PG as compared to endto-end or end-to-side PJ, no significant differences in mortality were observed between the groups, and the definition of pancreatic fistula was not uniform among the studies included in the meta-analysis. 40 The prospective, randomized, single-institution study presented in the current study was designed to test the hypothesis that PG is safer than PJ. The randomization provided comparable populations in the PG and PJ arms (Tables 1 and 2 ), and the primary study end point, the rate of pancreatic fistula, was similar in a comparison of PG and PJ (Table 3) . Secondary study end points, such as the incidence of postoperative complications and the postoperative length of stay, were also similar between the PG and PJ groups (Table 3) , thereby indicating no outcome advantage for either group. It is important to note that this study was performed in an institution with a high volume of pancreaticoduodenectomies per year" 4' and by a group of surgeons with extensive experience in pancreatic resection. Although our data indicate no advantage of either PG or PJ regarding shortterm outcomes, such as pancreatic fistula or other complications, additional follow-up is needed to evaluate differences in such parameters as patient survival or long-term pancreatic function.
The introduction of a newer technique (such as PG) into surgical practice is anticipated to result in a higher rate of early failure or complications, a phenomenon known as the "learning curve." In our institution, PJ was the standard means of restoring pancreatic-enteric continuity until 1991, at which time we began to use PG in selected cases. During the period of the current prospective randomized trial, no significant differences were observed in the rates of pancreatic fistula in a comparison ofthe first halfofthe trial to the second half, implying no role for a learning-curve phenomenon.
In earlier studies, researchers have evaluated the nontechnical factors that predispose to pancreatic fistula after pancreatic-enteric anastomosis. The results were conflicting, but such factors as age older than 65 years, preoperative jaundice, small pancreatic duct, "soft" pancreas, emergency operation, and large intraoperative blood loss have all been associated with an increased risk of pancreatic fistula.2'42'43 In the current study (Table 4) , demographic factors, such as age, sex, and race, were not statistically associated with pancreatic fistula, nor were any preoperative history findings or laboratory values.
Intraoperative parameters, such as increased operative time, increased blood replacement, and soft pancreatic texture, were found to positively correlate with the risk of pancreatic fistula on univariate analysis (p < 0.05).
However, these parameters failed to maintain their statistical significance in the multivariate model. No significant correlation was noted between the incidence of pancreatic fistula and other intraoperative or technical factors, such as length of mobilized pancreatic remnant, pancreatic duct diameter, inclusion of the pancreatic duct in the inner layer of the anastomosis, or drain contact with the anastomosis.
In the stepwise multivariate logistic regression analysis (Table 5) , the two strongest predictors of pancreatic fistula were lower patient volume per surgeon and primary ampullary or duodenal disease. The correlation between patient volume per surgeon and pancreatic fistula was significant (r = -0.91; p = 0.03) and was associated with a generally increasing odds ratio for pancreatic fistula as the number of cases decreased. The association between pancreatic fistula and ampullary or duodenal disease was also strong, with odds ratios for pancreatic fistula of 5.43 and 12.63, respectively. Covariate analysis revealed that disease was significantly correlated with pancreatic texture (p < 0.001), but multivariate analysis revealed disease to be a better predictor ofpancreatic fistula than texture.
In addition to the choice of PG versus PJ, another strategy proposed as a means of reducing the incidence of pancreatic fistula after pancreaticoduodenectomy involves the use of prophylactic octreotide therapy. Somatostatin and its octapeptide analogue, octreotide, have been reported to decrease the volume, amylase content, and bicarbonate content of pancreatic juice in human external pancreatic fistulas seen after pancreatic resection44 or transplantation.45 Such inhibition of pancreatic exocrine function serves as a rationale for the use of octreotide as prophylaxis against the development of pancreatic fistula for patients undergoing pancreaticoduodenectomy. Two In the current series, treatment for the 17 patients with pancreatic fistula included maintenance of intraoperatively placed drains for 14 patients (82%) and percutaneous drainage for 3 patients (18%). No patient required reoperation for drainage. All pancreatic fistulas closed without the need for completion pancreatectomy or revision of the pancreatic anastomosis. Adjuncts used in the treatment of pancreatic fistulas included octreotide (100%) and total parenteral nutrition (94%). For many patients with pancreatic fistula, oral intake was prohib-PG vs. PJ After Pancreaticoduodenectomy 587 ited. For some patients with pancreatic fistula, radiographic studies performed through the intraoperatively placed drains revealed the drain to be in direct contact with the leaking pancreatic-enteric anastomosis. In these cases, the drain was advanced out a short distance, allowing the disrupted or leaking anastomosis to heal.
In the current study, pancreatic fistula significantly lengthened hospital stay and was often accompanied by other serious complications, such as delayed gastric emptying, cholangitis, and abscess formation (Table 6 ). Although there were no deaths among the patients studied, pancreatic fistula undoubtedly is associated with lifethreatening complications, such as bleeding and sepsis. Additional studies, therefore, will be necessary to determine the safest means of performing a pancreatic-enteric anastomosis.
In conclusion, this prospective, randomized single-institution study has demonstrated that pancreatic fistula is a common complication after pancreaticoduodenectomy. Pancreatic fistula is most strongly associated with lower patient volume per surgeon and ampullary or duodenal disease. These data do not support the hypothesis that PG is safer than PJ or that it is associated with a lower incidence of pancreatic fistula. Discussion DR. JONATHAN E. RHOADS (Philadelphia, Pennsylvania): This is a superb study and could hardly have been done anywhere else that I know of because they accumulated 145 cases in about 20 months in one institution. A little over half of the cases were done by one surgeon-and perhaps you can guess who that was. And I always wonder when considering the allocations ofthe risks to the experience ofthe surgeons, whether it is the experience that counts or whether it is the success of the surgeon that attracts the cases.
In any case, as you have heard, this operation was done first, I believe, by Dr. John Waugh, who unfortunately died rather early and did not extend the series. We became aware of the operation through a publication by Millboum in the Acta Chirurgia Scandinavica, who reported seven successful cases in 1958. And he said that the procedure had been carried out in England between the time of John Waugh and Clagett's paper and his.
The reason we were interested in it is that we had had a bad experience with anastomosis to the jejunum. Our most fatal complication of pancreatic resection in the 1950s was hemorrhage. The pancreatic juice is activated by the succus entericus,
